PharmaResearch, a leader in regenerative medicine, hosted an official launch symposium for its Polynucleotide (PN)-based skin boosters, including Rejuran, Rejuran I, and Rejuran S, on the 14th in Budapest, Hungary. This event signifies the company's commitment to penetrate the local market and enhance its European operations.
The symposium took place at the Budapest Museum of Fine Arts, Hungary's premier national art institution, marking the first collaboration between PharmaResearch and the museum. This collaboration was instrumental in showcasing the clinical experience and brand philosophy that Rejuran has accrued, as well as communicating the premium brand value and scientific identity of Rejuran. Approximately 100 local medical professionals from dermatology and plastic surgery attended the event.
Key Opinion Leaders (KOLs) from Korea, including Dr. Park Hyun-jun and Dr. Lee Kyu-ho, alongside clinicians from Czech Republic, Slovakia, and Hungary, participated as speakers. They introduced the principles of PN-based skin regeneration and shared a variety of clinical cases and procedural experiences from their respective countries.
Particularly, the Korean medical professionals emphasized the distinct characteristics of each product, including Rejuran for overall facial application, Rejuran I for delicate areas like the eyes, and Rejuran S for treating wrinkles and scars. A live demonstration showcased Rejuran treatment protocols alongside essential clinical points to consider during actual procedures.
In Hungary, interest in 'Skin Quality' treatments, which prioritize the natural health and improvement of skin over conventional injectable procedures like botulinum toxin and hyaluronic acid fillers, is growing. As patients become more knowledgeable about aesthetic treatments, there is a trend favoring natural results with shorter recovery times. Additionally, medical professionals are increasingly interested in multi-procedural protocols that can be integrated with existing injectables and energy-based devices (EBD).
With this launch, PharmaResearch aims to solidify the presence of its three Rejuran products in Hungary. The company plans to expand its network of clinics and medical professionals in major cities through local partnerships, while also providing product education and hands-on training to support actual clinical application. Furthermore, regional workshops will involve healthcare providers from Hungary and neighboring countries to progressively strengthen the academic and business foundation across Europe.
A representative from PharmaResearch stated, “This launch event goes beyond mere product introduction. It enhances the understanding and potential utilization of Rejuran among local medical professionals by sharing the clinical experience and procedural know-how accumulated in Korea. We will continue to support the establishment of Rejuran in Hungary while seeking to expand into major European markets, thus enhancing our market foundation and brand competitiveness.”
PharmaResearch manufactures and sells pharmaceuticals, medical devices, cosmetics, and health supplements utilizing DOT®PDRN and DOT®PN substances based on regenerative medicine. Their product lineup includes brands such as Rejuran®, Rejuvenil®, Rejuran Cosmetics, Reentox®, Evercle®, Rejuderm®, Rejuvenex®, and Zyner.
